Sagentia, Premaitha Partner on IVD for Prenatal Screening | GenomeWeb

NEW YORK (GenomeWeb) – Sagentia and Premaitha Health today said they are partnering to develop a non-invasive in vitro diagnostic test to determine the risk of conditions such as Down syndrome.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.